NAD Recommends Motherlove Herbal Company Discontinue Certain Claims for ‘More Milk Plus,’ Finds Company Can Support Limited ‘Best-Selling’ Claim
New York, NY – July 21, 2015 – The National Advertising Division has recommended that Motherlove Herbal Company discontinue claims that the company’s “More Milk Plus” dietary supplement is an “effective herbal formula designed to quickly increase breast milk for breastfeeding mothers.” NAD determined, however, that the advertiser established a reasonable basis for the claim that More Milk Plus is “Motherlove’s best selling herbal lactation formula.”
NAD is an investigative unit of the advertising industry’s system of self-regulation. It is administered by the Council of Better Business Bureaus.
Claims made by Motherlove at the company website and in print advertising came to the attention of NAD through NAD’s routine monitoring. Express claims at issue in this inquiry included:
• “Motherlove’s best selling herbal lactation formula. A safe and effective herbal formula designed to quickly increase breast milk for breastfeeding mothers.”
• “Best selling breastfeeding supplement in the U.S.”
• “Fenugreek is a highly recommended herb to quickly increase breast milk supply.”
NAD also examined claims made in testimonials, including:
• “I had already noticed a difference, now after a week of using it, I have more than doubled my supply!”
• “Within 24 hours I was full of milk, really overflowing . . . I was so happy and surprised.”
• “Within 3 days of taking More Milk Plus he stayed latched on longer, and I had a whole day’s worth of bottles in the fridge the night before he needed them.”
• “Within a day or two, I noticed and felt a significant change in milk flow.”
NAD noted in its decision that the advertiser provided numerous reference articles and monographs on the product’s ingredients and properties, but did not provide evidence of testing on the actual product.
NAD next reviewed the evidence on the individual ingredients contained in the More Milk Plus proprietary blend: Fenugreek seed, Blessed Thistle herb, Nettle herb, and Fennel seed. NAD determined there was insufficient evidence in the record that Blessed Thistle herb, Fennel seed, and Nettle herb, in the dosage in which they are used in More Milk Plus, will have an effect on milk supply.
With regard to Fenugreek, NAD noted that amount of Fenugreek in the daily dose of More Milk Plus is less than the dosage amount found to be efficacious in the studies cited by the Canada’s Natural and Non-prescription Health Products Directorate monograph on Fenugreek – which the advertiser relied on to support its ingredient efficacy claims.
Following its review of the evidence in the record, NAD recommended that the advertiser discontinue its claim that More Milk Plus is an “effective herbal formula designed to quickly increase breast milk for breastfeeding mothers” as well as its consumer testimonials regarding the performance benefits of More Milk Plus.
Given the lack of evidence that the dosage of Fenugreek in the product provides any therapeutic benefit, NAD recommended that the advertiser discontinue its claim that “Fenugreek is a highly recommended herb to quickly increase breast milk supply.”
Finally, NAD determined that the advertiser established a reasonable basis for the claim that More Milk Plus is “Motherlove’s best selling herbal lactation formula.”
The company, in its advertiser’s statement, said it disagrees with “some of NAD’s conclusions regarding the evidence underlying express and testimonial performance claims for More Milk Plus.” However, the company said, it does “support the self-regulatory process and will take the NAD’s conclusions and recommendations into account.”
Subscribe to the Ad Law Insights or Privacy Initiatives newsletters for an exclusive monthly analysis and insider perspectives on the latest trends and case decisions in advertising law and data privacy.
Latest Decisions
Direct Selling Self-Regulatory Council Recommends Valentus Discontinue Earnings and Product Performance Claims
McLean, VA – December 23, 2024 – The Direct Selling Self-Regulatory Council (DSSRC) recommended Valentus, a direct selling company that sells nutritional and lifestyle products, discontinue earnings and health-related product performance claims made on social media and on the Valentus website.
Direct Selling Self-Regulatory Council Refers Olive Tree Earnings Claims to the FTC and California AG for Possible Enforcement Action
McLean, VA – December 20, 2024 – The Direct Selling Self-Regulatory Council (DSSRC) referred Olive Tree to the Federal Trade Commission (FTC) and California Attorney General's Office for possible enforcement action after Olive Tree failed to respond to a DSSRC inquiry into earnings claims.
Children’s Advertising Review Unit Recommends JustPlay Discontinue or Modify Daisy the Yoga Goat Claims
New York, NY – December 19, 2024 - The Children’s Advertising Review Unit (CARU) launched an investigation into advertising for Just Play’s furReal Daisy the Yoga Goat seeking to determine if the toy’s product packaging and commercial advertisements comply with CARU’s Self-Regulatory Guidelines for Children’s Advertising.
In National Advertising Division Fast-Track SWIFT Challenge, Oral Essentials Voluntarily Modifies “Made in USA” Claims
New York, NY – December 19, 2024 – In a National Advertising Division challenge, Oral Essentials agreed to permanently modify its claim that certain Oral Essentials oral healthcare products are “Made in USA.”